← Evidence map

ArticleSignal transduction and targeted therapy2024

Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38461173